Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis

M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection

(2017) Bin Wei et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein reflect the severity of chronic pancreatitis

(2017) Takashi Fujiyama et al.   Journal of Digestive Diseases

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury

(2017) Kei Morio et al.   JOURNAL OF GASTROENTEROLOGY

Gluten-induced cognitive impairment (“brain fog”) in coeliac disease

(2017) Gregory W Yelland   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis

(2017) Kiyoaki Ito et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2

(2017) Takao Watanabe et al.   JOURNAL OF MEDICAL VIROLOGY

Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment

(2017) Ka-Shing Cheung et al.   Oncotarget

Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis

(2017) Masato Nakamura et al.   PLoS One

Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression

(2016) Lei Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy

(2016) Hiroko Nagata et al.   Hepatology International

Clinical implications of serumWisteria floribundaagglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B

(2016) Akio Ishii et al.   HEPATOLOGY RESEARCH

SerumWisteria floribundaagglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection

(2016) Yuki Ichikawa et al.   HEPATOLOGY RESEARCH

Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers

(2016) Masayuki Mizuno et al.   HEPATOLOGY RESEARCH

Clinical implication of serumWisteria floribundaagglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients

(2016) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis

(2016) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

(2016) Eisuke Miyaki et al.   HEPATOLOGY RESEARCH

Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia

(2016) Naoya Yamada et al.   JOURNAL OF GASTROENTEROLOGY

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study

(2016) H. Nishikawa et al.   JOURNAL OF VIRAL HEPATITIS

Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development

(2016) Seung Up Kim et al.   LIVER INTERNATIONAL

Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

(2016) Xia Zou et al.   LIVER INTERNATIONAL

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation

(2016) Hiroki Nishikawa et al.   MEDICINE

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus

(2016) Ja Yoon Heo et al.   MEDICINE

Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma

(2016) Yuichi Waragai et al.   PANCREATOLOGY

Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis

(2016) Masato Kono et al.   RESPIRATORY MEDICINE

Hepatic steatosis and fibrosis: Non-invasive assessment

(2016) Rustam N Karanjia et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C

(2015) K. Ura et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis

(2015) Takeji Umemura et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treatment of Hepatitis C in Patients with Cirrhosis: Remaining Challenges for Direct-Acting Antiviral Therapy

(2015) Avik Majumdar et al.   DRUGS

Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics

(2015) Hisashi Narimatsu   Expert Review of Proteomics

Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study

(2015) Jeffrey Cui et al.   HEPATOLOGY

Wisteria floribundaagglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

(2015) Nobuharu Tamaki et al.   HEPATOLOGY RESEARCH

Impact of serumWisteria floribundaagglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Impact of serum glycosylatedWisteria floribundaagglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis

(2015) Tatsunori Hanai et al.   HEPATOLOGY RESEARCH

Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

(2015) Masato Fujiyoshi et al.   JOURNAL OF GASTROENTEROLOGY

Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

(2015) Hidenori Toyoda et al.   LIVER INTERNATIONAL

Non-invasive diagnosis of liver fibrosis and cirrhosis

(2015) Yoav Lurie   WORLD JOURNAL OF GASTROENTEROLOGY

Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics

(2015) Roxana Şirli   WORLD JOURNAL OF GASTROENTEROLOGY

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

(2014) Ali A Mokdad et al.   BMC Medicine

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

(2014) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

Natural history of hepatitis C

(2014) Rachel H. Westbrook et al.   JOURNAL OF HEPATOLOGY

A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment

(2013) Minoti V. Apte et al.   GASTROENTEROLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver

(2011) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update

(2011) Giacomo Germani et al.   SEMINARS IN LIVER DISEASE

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

(2010) Masakuni Tateyama et al.   JOURNAL OF GASTROENTEROLOGY

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

(2009) Guadalupe Garcia-Tsao et al.   HEPATOLOGY

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Noninvasive Evaluation of Hepatic Fibrosis Using Serum Fibrotic Markers, Transient Elastography (FibroScan) and Real-Time Tissue Elastography

(2008) Chie Tatsumi et al.   INTERVIROLOGY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET